Impact of team‐based care on appropriate statin therapy prescribing in HIV‐infected patients

Introduction Statins have historically been underutilized in patients living with ***HIV infection (PLWH) despite reported rates of cardiovascular disease twice that of the general population. Objective To evaluate the impact of team‐based pharmacy services on appropriate statin prescribing compared with standard care in an HIV primary care clinic. Methods A retrospective chart review of adult PLWH was conducted for appropriate statin prescribing according to 2013 American College of Cardiology/American Heart Association cholesterol guidelines. Patient outcomes were stratified by team‐based care defined as physician/pharmacy collaboration, and standard care defined as primary care without clinical pharmacy services. The primary outcome was the percentage of patients receiving appropriate statin therapy in the two groups. Secondary outcomes included percentage of patients receiving appropriate statin therapy, number of patients indicated for therapy but untreated, and achievement of low‐density lipoprotein (LDL) goal reduction. Chi‐square analysis was used for nominal comparisons, and logistic regression was used to identify predictors of appropriate statin prescribing. Results Three hundred fifty‐two charts were screened, 114 of which met inclusion criteria. Eighty‐nine patients (61%) received team‐based care and 25 (22%) received standard care. Appropriate statin prescribing was observed in a greater percentage of patients in the team‐based care group compared with the standard care group (86% vs 54%, respectively; P